JP2001509679A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509679A5
JP2001509679A5 JP1998534602A JP53460298A JP2001509679A5 JP 2001509679 A5 JP2001509679 A5 JP 2001509679A5 JP 1998534602 A JP1998534602 A JP 1998534602A JP 53460298 A JP53460298 A JP 53460298A JP 2001509679 A5 JP2001509679 A5 JP 2001509679A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998534602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001509679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/000959 external-priority patent/WO1998031799A2/en
Publication of JP2001509679A publication Critical patent/JP2001509679A/ja
Publication of JP2001509679A5 publication Critical patent/JP2001509679A5/ja
Withdrawn legal-status Critical Current

Links

JP53460298A 1997-01-21 1998-01-21 レセプターをコードするポリヌクレオチドとポリペプチド Withdrawn JP2001509679A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3420597P 1997-01-21 1997-01-21
US3420497P 1997-01-21 1997-01-21
US60/034,204 1997-01-21
US60/034,205 1997-08-05
PCT/US1998/000959 WO1998031799A2 (en) 1997-01-21 1998-01-21 Polynucleotides and polypeptides encoding receptors

Publications (2)

Publication Number Publication Date
JP2001509679A JP2001509679A (ja) 2001-07-24
JP2001509679A5 true JP2001509679A5 (enExample) 2005-09-08

Family

ID=26710688

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53460298A Withdrawn JP2001509679A (ja) 1997-01-21 1998-01-21 レセプターをコードするポリヌクレオチドとポリペプチド
JP53460398A Withdrawn JP2001509029A (ja) 1997-01-21 1998-01-21 ヒトタンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP53460398A Withdrawn JP2001509029A (ja) 1997-01-21 1998-01-21 ヒトタンパク質

Country Status (6)

Country Link
US (8) US6653445B1 (enExample)
EP (2) EP0972022A2 (enExample)
JP (2) JP2001509679A (enExample)
AU (2) AU6030398A (enExample)
CA (2) CA2278118A1 (enExample)
WO (2) WO1998031799A2 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
CA2278118A1 (en) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
US6605699B1 (en) 1997-01-21 2003-08-12 Human Genome Sciences, Inc. Galectin-11 polypeptides
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
EP1005546A2 (en) 1997-02-25 2000-06-07 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6146845A (en) * 1997-04-02 2000-11-14 Smithkline Beecham Corporation Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
US6485933B1 (en) 1997-05-07 2002-11-26 Incyte Genomics, Inc. B cell receptor associated proteins
EP0879880A1 (en) * 1997-05-22 1998-11-25 Smithkline Beecham Corporation ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
US5849528A (en) * 1997-08-21 1998-12-15 Incyte Pharmaceuticals, Inc.. Polynucleotides encoding a human S100 protein
CA2218199A1 (en) * 1997-12-09 1999-06-09 Mcgill University Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
AU4969599A (en) * 1998-07-06 2000-01-24 Human Genome Sciences, Inc. Galectin 11
US6168920B1 (en) 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
US7538086B2 (en) * 1998-09-01 2009-05-26 Genentech, Inc. PRO1303 polypeptides
NZ510464A (en) * 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
AU2985200A (en) * 1999-02-03 2000-08-25 Immunex Corporation Novel sialoadhesins
CA2371611A1 (en) * 1999-04-21 2000-10-26 Jian Ni Galectin 11
DE60042799D1 (de) * 1999-06-09 2009-10-01 Genentech Inc Methoden zur Diagnose von Tumoren
AU2883700A (en) * 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6960651B2 (en) 1999-06-29 2005-11-01 Millennium Pharmaceuticals, Inc. TANGO 332 polypeptides
EP1194534A4 (en) * 1999-06-29 2004-03-24 Millennium Pharm Inc NOVEL GENES ENCODING PROTEINS THAT CAN BE USED IN DIAGNOSTIC, PREVENTIVE, THERAPEUTIC OR OTHER AREAS
US6914132B1 (en) 1999-06-30 2005-07-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6686447B1 (en) 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) * 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6858204B2 (en) 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030125245A1 (en) 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
NZ516381A (en) 1999-06-30 2004-03-26 Corixa Corp Lung tumor proteins in the therapy and diagnosis of lung cancer
US6504010B1 (en) 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2001002564A1 (fr) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Nouveau polypeptide et adn de ce polypeptide
US6746846B1 (en) 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
DE60129210T2 (de) 2000-02-29 2008-03-20 Mitsubishi Pharma Corp. Zyklische amid-derivate
EP1267907A1 (en) * 2000-03-23 2003-01-02 Akzo Nobel N.V. Use of mia in immunotherapy
WO2001096399A2 (en) * 2000-06-15 2001-12-20 Curagen Corporation Novel interferon-induced tetraspan protein and nucleic acids encoding same
US20040081972A1 (en) * 2000-08-01 2004-04-29 Mitsuo Satoh Novel physiologically active peptide and use thereof
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CN1373218A (zh) * 2001-02-28 2002-10-09 中国医学科学院阜外心血管病医院 炎性抑制因子Fwa116
WO2006007202A2 (en) * 2004-05-28 2006-01-19 Idexx Laboratories, Inc Canine cd20 compositions
US7495073B2 (en) * 2005-03-24 2009-02-24 Asia Hepato Gene Company Short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use
EP1980571B1 (en) * 2007-04-11 2010-10-13 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
WO2008125635A1 (en) * 2007-04-11 2008-10-23 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
US8372810B2 (en) * 2007-04-11 2013-02-12 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
TWI387750B (zh) * 2009-02-10 2013-03-01 Nat Defense Medical Ct Biomarker and detection method for detecting kidney disease
EP2496604B1 (en) * 2009-11-06 2017-08-23 IDEXX Laboratories, Inc. Canine anti-cd20 antibodies
US8637642B2 (en) 2010-09-29 2014-01-28 Seattle Genetics, Inc. Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
US20150301068A1 (en) * 2012-01-30 2015-10-22 Vib Vzw Means and method for diagnosis and treatment of alzheimer's disease
AU2019392090A1 (en) 2018-12-03 2021-06-17 Agensys, Inc. Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789413T2 (de) * 1986-10-03 1994-07-28 Ciba Geigy Ag Lymphokin-ähnliche Peptide.
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
FR2636953B1 (fr) * 1988-09-26 1990-12-14 Roussy Inst Gustave Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
SG66214A1 (en) * 1990-09-05 1999-07-20 Heart Research Inst Ltd Novel chemotactic factor
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5770366A (en) * 1993-07-20 1998-06-23 Boehringer Mannheim Gmbh Melanoma-inhibiting protein
US5527884A (en) * 1993-12-21 1996-06-18 President And Fellows Of Harvard College Mediators of chronic allograft rejection and DNA molecules encoding them
NZ301067A (en) * 1994-12-06 1998-03-25 Immunex Corp Cytokine designated lerk-7 for activating tyrosine kinases
WO1997004122A1 (en) * 1995-07-20 1997-02-06 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
CA2278118A1 (en) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
US6020478A (en) * 1997-02-28 2000-02-01 Incyte Pharmaceuticals, Inc. Human tumor-associated antigen
US5849528A (en) 1997-08-21 1998-12-15 Incyte Pharmaceuticals, Inc.. Polynucleotides encoding a human S100 protein
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins

Similar Documents

Publication Publication Date Title
JP2000509637A5 (enExample)
JP2000509635A5 (enExample)
JP2000509912A5 (enExample)
JP2000509942A5 (enExample)
JP2000507042A5 (enExample)
JP2002505002A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2001507464A5 (enExample)
JP2000508102A5 (enExample)
JP2000508836A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)